Ming Cao

1.9k total citations · 1 hit paper
57 papers, 1.3k citations indexed

About

Ming Cao is a scholar working on Biomedical Engineering, Surgery and Molecular Biology. According to data from OpenAlex, Ming Cao has authored 57 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Biomedical Engineering, 14 papers in Surgery and 14 papers in Molecular Biology. Recurrent topics in Ming Cao's work include Bladder and Urothelial Cancer Treatments (12 papers), Nanoplatforms for cancer theranostics (10 papers) and Nanoparticle-Based Drug Delivery (7 papers). Ming Cao is often cited by papers focused on Bladder and Urothelial Cancer Treatments (12 papers), Nanoplatforms for cancer theranostics (10 papers) and Nanoparticle-Based Drug Delivery (7 papers). Ming Cao collaborates with scholars based in China, Saudi Arabia and Italy. Ming Cao's co-authors include Haige Chen, Jinguo Wang, Wen Gao, Zhiqiang Chen, Xuehao Wang, Jindao Wu, Xueliang Zuo, Junfeng Wang, Juan Cai and Yao Zhang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Nature Immunology.

In The Last Decade

Ming Cao

54 papers receiving 1.3k citations

Hit Papers

M6A-mediated upregulation of LINC00958 increases lipogene... 2020 2026 2022 2024 2020 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. M6A-mediated upregulation of LINC00958 increases lipogenesis and acts as a nanotherapeutic target in hepatocellular carcinoma
    2020 338 citations Xueliang Zuo, Zhiqiang Chen et al. Journal of Hematology & Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming Cao China 19 739 464 291 153 141 57 1.3k
Rongliang Tong China 19 734 1.0× 430 0.9× 267 0.9× 53 0.3× 181 1.3× 33 1.3k
Beng Yang China 18 1.4k 1.8× 890 1.9× 185 0.6× 126 0.8× 142 1.0× 27 1.8k
Gongwei Wu China 15 814 1.1× 474 1.0× 189 0.6× 54 0.4× 183 1.3× 17 1.3k
Wenqing Jiang China 10 732 1.0× 612 1.3× 169 0.6× 43 0.3× 114 0.8× 25 1.7k
Shiyan Wang China 20 1.4k 1.9× 633 1.4× 183 0.6× 78 0.5× 134 1.0× 42 1.8k
Meng Pan China 19 416 0.6× 212 0.5× 346 1.2× 97 0.6× 158 1.1× 53 1.0k
Zhiwen Fan China 29 835 1.1× 222 0.5× 368 1.3× 287 1.9× 290 2.1× 83 2.0k
Haiying Wan China 18 713 1.0× 504 1.1× 155 0.5× 182 1.2× 244 1.7× 22 1.5k
Jia Feng China 16 677 0.9× 222 0.5× 144 0.5× 121 0.8× 80 0.6× 45 1.1k
Yun Liu China 21 419 0.6× 193 0.4× 162 0.6× 92 0.6× 267 1.9× 85 1.3k

Countries citing papers authored by Ming Cao

Since Specialization
Citations

This map shows the geographic impact of Ming Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Cao more than expected).

Fields of papers citing papers by Ming Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Cao. The network helps show where Ming Cao may publish in the future.

Co-authorship network of co-authors of Ming Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Cao. A scholar is included among the top collaborators of Ming Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Cao. Ming Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ding, Qiong, Changzhi Xu, Jibin Miao, et al.. (2025). PH-activated off/on nanosystem for combined photothermal/chemodynamic antibacterial application. Colloids and Surfaces A Physicochemical and Engineering Aspects. 709. 136116–136116. 2 indexed citations
2.
Zhu, Qingchen, Ming Cao, Huan Huang, et al.. (2025). Microbiota-shaped neutrophil senescence regulates sexual dimorphism in bladder cancer. Nature Immunology. 26(5). 722–736. 9 indexed citations
3.
Hu, Pengyi, et al.. (2025). Enhancing temozolomide efficacy in GBM: The synergistic role of chuanxiong rhizoma essential oil. Phytomedicine. 140. 156575–156575. 2 indexed citations
4.
Xia, Ru, et al.. (2025). Mutual boost between free radicals and photothermal effect for synergistic photothermal/thermodynamic antibacterial therapy. Colloids and Surfaces B Biointerfaces. 253. 114742–114742. 1 indexed citations
5.
6.
Zhang, Mingxia, Pengyi Hu, Jing Zhang, et al.. (2025). Exploratory Study on Nanoparticle Co-Delivery of Temozolomide and Ligustilide for Enhanced Brain Tumor Therapy. Pharmaceutics. 17(2). 191–191. 5 indexed citations
7.
Cheng, Long, et al.. (2025). A novel type of carbon dots for discriminating yeast cell viability and nuclear labeling. Food Bioscience. 68. 106797–106797.
8.
Xie, Zhixin, et al.. (2025). Activity detection of lactic acid bacteria based on fluorescence color difference of boron and nitrogen co-doped carbon dots. Food Bioscience. 64. 105880–105880. 3 indexed citations
9.
10.
Jin, Di, Lei Qian, Jun Xia, et al.. (2023). In vivo detection of circulating tumor cells predicts high-risk features in patients with bladder cancer. Medical Oncology. 40(4). 113–113. 2 indexed citations
11.
Zhou, Jialing, Hongyi Li, Hui Wang, et al.. (2023). Dynamic changes in three biomarkers predict early-stage hepatocellular carcinoma in patients with chronic hepatitis B receiving antiviral therapy. Journal of Cancer Research and Clinical Oncology. 149(14). 12691–12701. 1 indexed citations
12.
13.
Wang, Yiqiu, Zehua Ma, Lei Qian, et al.. (2022). Surface-Enhanced Raman Spectroscopy of Pretreated Plasma Samples Predicts Disease Recurrence in Muscle-Invasive Bladder Cancer Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy. SHILAP Revista de lepidopterología. 5 indexed citations
14.
Lei, Huali, Xianwen Wang, Fei Gong, et al.. (2020). Biodegradable Fe-Doped Vanadium Disulfide Theranostic Nanosheets for Enhanced Sonodynamic/Chemodynamic Therapy. ACS Applied Materials & Interfaces. 12(47). 52370–52382. 95 indexed citations
15.
Zuo, Xueliang, Zhiqiang Chen, Wen Gao, et al.. (2020). M6A-mediated upregulation of LINC00958 increases lipogenesis and acts as a nanotherapeutic target in hepatocellular carcinoma. Journal of Hematology & Oncology. 13(1). 5–5. 338 indexed citations breakdown →
16.
Xu, Yun, et al.. (2020). SNHG10 Promotes Cell Proliferation and Migration in Gastric Cancer by Targeting miR-495-3p/CTNNB1 Axis. Digestive Diseases and Sciences. 66(8). 2627–2636. 23 indexed citations
17.
Cao, Ming, Bin Wu, Lifen Su, et al.. (2020). Interface crosslinked mPEG-b-PAGE-b-PCL triblock copolymer micelles with high stability for anticancer drug delivery. Colloids and Surfaces B Biointerfaces. 189. 110830–110830. 23 indexed citations
18.
Cao, Ming, Xin Mu, Chen Chen Jiang, et al.. (2013). Single-nucleotide polymorphisms of GPX1 and MnSOD and susceptibility to bladder cancer: a systematic review and meta-analysis. Tumor Biology. 35(1). 759–764. 37 indexed citations
19.
Yang, Guoliang, et al.. (2012). Increased expression of HMGB1 is associated with poor prognosis in human bladder cancer. Journal of Surgical Oncology. 106(1). 57–61. 70 indexed citations
20.
Yang, Guoliang, Juanjie Bo, Haige Chen, et al.. (2011). UHRF1 is associated with tumor recurrence in non-muscle-invasive bladder cancer. Medical Oncology. 29(2). 842–847. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rongliang Tong Breakdown of academic impact, for papers by Beng Yang Breakdown of academic impact, for papers by Gongwei Wu Breakdown of academic impact, for papers by Wenqing Jiang Breakdown of academic impact, for papers by Shiyan Wang Breakdown of academic impact, for papers by Meng Pan Breakdown of academic impact, for papers by Zhiwen Fan Breakdown of academic impact, for papers by Haiying Wan Breakdown of academic impact, for papers by Jia Feng Breakdown of academic impact, for papers by Yun Liu
Rankless by CCL
2026